Determination of the Transplacental Transfer of Paclitaxel and Antipyrine by High Performance Liquid Chromatography Coupled with Photodiode Array Detector.

Journal: Journal of liquid chromatography & related technologies
Published Date:

Abstract

placental perfusion experiments are important in understanding the quantity and mechanisms of xenobiotic transport to the fetus during pregnancy. Our study demonstrates that paclitaxel and antipyrine concentrations in placental perfusion medium containing physiological concentrations of human serum albumin during pregnancy (30 mg/mL) can be quantified by RP-HPLC and UV detection. A liquid-liquid extraction method was developed for the quantification of paclitaxel and celecoxib (internal standard) from perfusion medium. Antipyrine, which is a necessary marker in placental perfusions for determining the validity of experiments and calculating the clearance index of xenobiotics, was also analyzed by HPLC and UV detection. Antipyrine concentrations were determined by HPLC after precipitating the perfusion medium in acetonitrile and separating the precipitated proteins by centrifugation. Concentrations were fitted to linear regressions with R values approaching 1. Lower limits of detection for paclitaxel and antipyrine were 100 ng/mL and 200 ng/mL, respectively. Both methods demonstrated high intra-day and inter-day precision and trueness. Additionally, the use of these methods was demonstrated in a placental perfusion experiment using Taxol (paclitaxel dissolved in Cremophor-EL). The fetal transfer rate of Taxol was 6.6% after 1 hour.

Authors

  • Shariq Ali
    Department of Pharmacology and Toxicology, The University of Texas Medical Branch, 301 University Blvd. Galveston, TX.
  • Norah Albekairi
    College of Pharmacy, King Saud University, King Khalid Road, Riyadh, Saudi Arabia.
  • Xiao-Ming Wang
    Department of Colorectal and Anal Surgery, Linzi District People's Hospital, Linzi, Shandong, P. R. China.
  • Svetlana Patrikeeva
    Department of Obstetrics and Gynecology, The University of Texas Medical Branch, 301 University Blvd. Galveston, TX.
  • Tatiana N Nanovskaya
    Department of Obstetrics and Gynecology, The University of Texas Medical Branch, 301 University Blvd. Galveston, TX.
  • Mahmoud S Ahmed
    Department of Pharmacology and Toxicology, The University of Texas Medical Branch, 301 University Blvd. Galveston, TX.
  • Erik Rytting
    Department of Pharmacology and Toxicology, The University of Texas Medical Branch, 301 University Blvd. Galveston, TX.

Keywords

No keywords available for this article.